Analytical Data
-
Gene name
TPD52L2
- Application
-
Alternative Names
2810411G23Rik; AU016537; C86069; D54; DKFZp686A1765; HCCR binding Protein 2; hD54; MGC73020; RP23 33L3.2; TPD52L2; TPD54; TPD54_HUMAN; tumor Protein D52 like 2; Tumor Protein D52-like 2; Tumor Protein D54
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O43399
-
Expression Region
1-206 aa
-
AA Sequence
MDSAGQDINL NSPNKGLLSD SMTDVPVDTG VAARTPAVEG LTEAEEEELR AELTKVEEEI VTLRQVLAAK ERHCGELKRR LGLSTLGELK QNLSRSWHDV QVSSAYVKTS EKLGEWNEKV TQSDLYKKTQ ETLSQAGQKT SAALSTVGSA ISRKLGDMRN SATFKSFEDR VGTIKSKVVG DRENGSDNLP SSAGSGDKPL SDPAPF
-
Molecular Weight
22.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TPD52L2 (Tumor Protein D52-Like 2) is a member of the TPD52 family, which is implicated in cancer biology and cellular signaling processes. The protein is associated with diverse cellular functions, including cell proliferation, differentiation, and apoptosis, making it a potential biomarker for various types of cancers. Research has shown that TPD52L2 may play a critical role in tumorigenesis, potentially influencing cancer cell growth and metastasis through its interactions with other signaling molecules. The overexpression of TPD52L2 has been observed in several malignancies, indicating its potential role as an oncogene. As a result, the study of TPD52L2, particularly its recombinant protein form, aims to elucidate its biological functions and mechanisms of action within the cell. By producing and characterizing TPD52L2 recombinant protein, researchers strive to gain insights into its structure-function relationship, thus fostering the development of targeted therapies that may disrupt its oncogenic activities. Understanding TPD52L2's role in cancer could ultimately contribute to novel diagnostic tools and therapeutics, enhancing the prognosis and treatment strategies for patients with malignancies. The exploration of TPD52L2 continues to be a promising avenue in the field of cancer research, with implications for understanding tumor biology and improving patient outcomes.
